← Back to Clinical Trials
Recruiting NCT06184295

NCT06184295 Robotic Balance Training to Improve Postural Control and Balance Post-Traumatic Brain Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06184295
Status Recruiting
Phase
Sponsor Kessler Foundation
Condition Traumatic Brain Injury
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-01-01
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
TBI - Intervention Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-01-01 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess a balance training program to see if it can be helpful to improve balance and avoid falls in people who have had traumatic brain injuries (TBIs). The study will involve three groups of research subjects: 1) TBI-intervention group, 2) TBI- non-intervention group and 3) the participants without disability group. The TBI intervention Group will participate in 10 robotic balance training sessions. Data will collected pre and post-training. TBI- non-intervention group will not receive any training. They will participate in two data collection sessions which are about 5 weeks apart. The participants without disability group will not receive any training. They will participate in one data collection session.

Eligibility Criteria

Participants with TBI: Inclusion Criteria: * Be between the ages of 18 and 65. * Have been diagnosed with a TBI by a physician and be at least 6 months post injury and not more than 5 years post injury. * Have been medically stable for 3 months prior to the most recent TBI. * Not plan to make any drastic changes to medications (as determined by study staff) for at least 4 weeks. * Be able to stand unsupported for 5 minutes. * Be willing and able to give informed consent. * Be able and willing to comply with study procedures, verbal instructions, and follow-up requirements. Exclusion Criteria: * Weight above 300 lbs. * Have severe cardiac disease such as heart attack or moderate or severe congestive heart failure. * Have a pre-existing condition resulting in significant disruption in alignment or function of the lower limb during standing. * Have additional medical conditions that affect the bones, muscles or nerves that would interfere with the balance. * Have any previously diagnosed history of balance problems prior to TBI. * Have fluctuating blood pressure. * Be on any medication that may affect balance, strength, or muscle coordination (e.g. Botox). * Be currently enrolled in another research study that is likely to affect participation in this research study. * Have seizure disorder. Participants without a disability: Inclusion Criteria: * Be between the ages of 18 and 65. * Not plan to make any drastic changes to medications for at least 4 weeks. * Not have an orthopedic, cognitive or neuromuscular disease. * Be able to stand unsupported for 5 minutes. * Be willing and able to give informed consent. * Be able and willing to comply with study procedures, including follow-up requirements. Exclusion Criteria: * Weight above 300 lbs. * Have a history of injury to my lower limbs in the past 90 days. * Have severe cardiac disease such as heart attack or moderate or severe congestive heart failure. * Have a pre-existing condition resulting in significant disruption in alignment or function of the lower limb during standing. * Have any additional medical conditions that affect my bones, muscles, or nerves that would interfere with the movement or the ability to feel touch or pain. * Have difficulty following or responding to commands that would limit the study participation. * Be currently enrolled in another research study that is likely to affect participation in this research study.

Contact & Investigator

Central Contact

Kiran Karunakaran, Ph.D.

✉ kkarunakaran@kesslerfoundation.org

📞 973-324-3590

Principal Investigator

Kiran Karunakaran

PRINCIPAL INVESTIGATOR

Kessler Foundation

Frequently Asked Questions

Who can join the NCT06184295 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06184295 currently recruiting?

Yes, NCT06184295 is actively recruiting participants. Contact the research team at kkarunakaran@kesslerfoundation.org for enrollment information.

Where is the NCT06184295 trial being conducted?

This trial is being conducted at West Orange, United States.

Who is sponsoring the NCT06184295 clinical trial?

NCT06184295 is sponsored by Kessler Foundation. The principal investigator is Kiran Karunakaran at Kessler Foundation. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology